Tribunal Rules USFDA Fees May Be Taxable, Case Sent Back to Assess Service Nature and Government Entity Status.

The Tribunal upheld the order remanding the case to the Adjudicating Authority to determine if fees paid to USFDA for medicament approval constitute a service liable to Service Tax under the Finance Act, 1994. The appellant's argument that the fees were statutory and not for a service was rejected. The Tribunal emphasized the need to assess whether USFDA is a government entity under the 'Negative List', which would affect the taxability. The appeal was dismissed, allowing further examination of the issue by the Adjudicating Authority.

---

---

Issues: Whether fees paid to USFDA for approval of medicaments can be treated as a service under Finance Act, 1994 and liable to Service Tax on reverse charge basis.

Summary:
The appeal challenged an order remanding the matter to the Adjudicating Authority to examine the issue of whether fees paid to USFDA constitute a service for Service Tax liability. The appellant argued that the fees were statutory and not for any service, thus no Service Tax was due. The revenue contended that the taxability of the activity was in question, and the remand was justified. The Tribunal found that the key issue was whether the fees constituted a service, dependent on whether USFDA should be considered a government entity under the 'Negative List'. The Tribunal disagreed with the appellant's claim that the issue was settled in the original order, as the nature of the activity as a service or not was crucial. The remand was deemed appropriate to allow the appellant to present their case before the Adjudicating Authority. Consequently, the impugned order was upheld, and the appeal was dismissed.

---